Health Condition 1: I671- Cerebral aneurysm, nonruptured Health Condition 2: I602- Nontraumatic subarachnoid hemorrhage from anterior communicating artery Health Condition 3: I604- Nontraumatic subarachnoid hemorrhage from basilar artery Health Condition 4: I600- Nontraumatic subarachnoid hemorrhage from carotid siphon and bifurcation Health Condition 5: I601- Nontraumatic subarachnoid hemorrhage from middle cerebral artery Health Condition 6: I606- Nontraumatic subarachnoid hemorrhage from othe
Conditions
Interventions
Intervention1: Intravenous infusion of dexmedetomidine as an adjunct anaesthetic / sedative agent: Patient undergoing endovascular procedures will be administered intravenous dexmedetomidine infusion
Sponsors
Dr Mathew George
Dr Prem Nair
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with intracranial aneurysms who are planned for elective endovascular therapy by coiling under general anaesthesia
Exclusion criteria
Exclusion criteria: Patients who are known to be allergic to dexmedetomidine. Patients who are on ventilatory support pre-procedure and unable to give consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-procedure intracerebral vasospasm as asessed by drop in conscious level, development of new focal deficit or as assessed by transcranial doppler criteriaTimepoint: Vasospasm will be evaluated upto 48 hours post procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the degree of disability in patients undergoing aneurysm coiling or stenting at the time of dischargeTimepoint: 1 month following the procedure | — |
Countries
India
Contacts
Public ContactDr Neethu Rebecca Isaac
Amrita Institute of Medical Sciences and Research center
Outcome results
None listed